Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohamad S. Draman"'
Autor:
Bhaskar Dasgupta, Mohamad S. Draman, Holly J. Garringer, Daniel L. Koller, Niamh Conlon, Siobhan I. Davis, Neal S. Fedarko, Alka Jain, Kenneth E. White, Corinne Fisher, M. J. Cullen, Tobias E. Larsson
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:4037-4042
Context: Familial tumoral calcinosis (TC) results from disruptions in phosphate metabolism and is characterized by high serum phosphate with normal or elevated 1,25 dihydroxyvitamin vitamin D concentrations and ectopic and vascular calcifications. Re
Autor:
Siobhan I. Davis, Tobias E. Larsson, Xijie Yu, Mohamad S. Draman, M. J. Cullen, Kenneth E. White, Sean D. Mooney
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:2424-2427
Gain-of-function mutations in fibroblast growth factor-23 (FGF23) are responsible for autosomal dominant hypophosphatemic rickets, a disorder of isolated renal phosphate wasting. Patients with the disorder display hypophosphatemia with normocalcemia
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
Autor:
Holly J. Garringer, Kenneth E. White, Mohamad S. Draman, Tobias E. Larsson, M. J. Cullen, Sean D. Mooney, Siobhan I. Davis
Publikováno v:
Endocrinology. 146(9)
Familial tumoral calcinosis (TC, OMIM 211900) is a heritable disorder characterized by hyperphosphatemia, normal or elevated serum 1,25-dihydroxyvitamin D, and often severe ectopic calcifications. Two recessive mutations in fibroblast growth factor-2